Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
16.7%
% of MEDX's 30 holdings also in OZEM
20.8%
% of OZEM's 25 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.8% | 17.7% | 16.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% | 5.2% | 5.2% |
|
AMGEN INC | 6.3% | 4.7% | 4.7% |
|
PFIZER INC | 4.0% | 3.7% | 3.7% |
|
REGENERON PHARMACEUTICALS | 2.8% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to OZEM
|
ABBVIE INC | 9.6% |
 |
NOVARTIS AG-ADR | 6.6% |
|
BRISTOL-MYERS SQUIBB CO | 6.5% |
|
JOHNSON & JOHNSON | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
 |
ALKERMES PLC | 4.7% |
|
MERCK & CO. INC. | 3.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
BIOGEN IDEC INC | 2.6% |
|
CRISPR THERAPEUTICS AG | 2.4% |
MEDX Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -12.7% |
|
ROCHE HOLDING LTD | -6.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
GILEAD SCIENCES INC | -2.7% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.4% |
|
VIKING THERAPEUTICS, INC. | -2.3% |